Cladribine Intravenous and Neurological disorders
Result of checking the interaction of drug Cladribine Intravenous and disease Neurological disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Severe unspecified neurological toxicity has been reported rarely during cladribine therapy administered at therapeutic doses. Serious neurological toxicity such as irreversible paraparesis and quadriparesis has been reported in patients receiving four to nine times the recommended dosage of cladribine for hairy cell leukemia. Therapy with cladribine should be administered cautiously to patients with or predisposed to neurological impairment.
- "Product Information. Leustatin (cladribine)." Ortho Biotech Inc, Raritan, NJ.
Generic Name: cladribine
Brand Name: Mavenclad, Leustatin
Synonyms: Cladribine